Veterinary Pharmaceutical Supply – Ropinirole Ophthalmic Solution

The contract involves the supply of an FDA-compliant Ropinirole Ophthalmic Solution, known as Clevor Solution, specifically formulated for veterinary use in dogs and packaged in single-use droppers to ensure sterility and ease of administration. The product must fully comply with all applicable FDA standards for pharmaceuticals, including strict requirements for packaging, labeling, and regulatory documentation to ensure safety, potency, and consistency across batches. The solution is intended for ocular treatment in canine patients and must meet all quality control benchmarks expected for human-grade pharmaceuticals even though it is designated for veterinary applications. The contract is classified as a subcontract under NAICS code 325412, indicating it pertains to pharmaceutical and medicine manufacturing, and is issued by the Department of Defense through the Medical Supply Chain Pharm FSA. The place of performance is listed as APO with ZIP code 09227-0000, suggesting delivery or fulfillment arrangements tied to military logistics channels. The solicitation was posted on May 12, 2026, with a firm response deadline of May 18, 2026, indicating a short turnaround window for potential suppliers to submit proposals. Although no specific set-aside or point of contact details are provided, the requirement implies a need for qualified manufacturers with experience in sterile ophthalmic formulations and the ability to meet stringent federal procurement standards for pharmaceuticals used in military veterinary services.